An endurance athlete spending two years in a performance plateau, chronically fatigued, with an unexplained anaemia that iron supplementation doesn't resolve. The diagnosis nobody tested for: coeliac disease.
Coeliac disease affects approximately 1% of the global population, but diagnosis is delayed an average of 6–10 years from symptom onset (Fasano 2012). In athletes, the presentation is often subtler than the textbook diarrhoea-and-bloating picture: unexplained fatigue, low ferritin unresponsive to supplementation, stress fractures, depressed immune function, and training plateaus. The reason coeliac disease is particularly damaging to athletic performance is the mechanism of harm — not just inflammation, but nutrient malabsorption from villous atrophy.
---
The Intestinal Architecture Problem
Coeliac disease is an autoimmune condition triggered by dietary gliadin (a gluten protein fraction from wheat, rye, and barley). In genetically susceptible individuals (HLA-DQ2 or HLA-DQ8 carriers), gliadin exposure activates tissue transglutaminase (tTG2), triggering an IL-15-driven T-cell immune response that progressively destroys intestinal villi — the finger-like projections that provide absorptive surface area in the small intestine.
Healthy intestinal villi provide a surface area approximately equivalent to a tennis court (250–300 m²). In active coeliac disease with Marsh grade III villous atrophy, this is reduced to near-flat mucosa — dramatically impairing absorption of iron, vitamin B12, folate, calcium, zinc, vitamin D, and fat-soluble vitamins (A, E, K).
For athletes, this creates a perfect storm: high nutritional demands from training, simultaneously impaired by a gut architecture that cannot absorb the nutrients provided.
---
The Iron Malabsorption Problem
Duodenal absorptive cells (enterocytes) are the primary site of non-haem iron absorption. Villous atrophy specifically targets the duodenum and proximal jejunum — exactly where iron absorption is maximal. Athletes with undiagnosed coeliac disease commonly present with iron deficiency anaemia that responds poorly or not at all to oral iron supplementation, because the mucosal surface responsible for iron uptake is damaged.
Kaukinen and colleagues (2015, Alimentary Pharmacology and Therapeutics) found that 15–46% of newly diagnosed coeliac patients had iron deficiency anaemia as the sole presenting symptom. In this population, anaemia resolved on a strict gluten-free diet (GFD) within 6–12 months as intestinal architecture recovered — without any additional iron therapy.
For athletes with low ferritin unresponsive to oral iron supplementation, coeliac serology (tissue transglutaminase IgA antibody, endomysial antibody) should be a standard diagnostic step.
---
B12, Folate, and the Cognitive-Athletic Connection
Vitamin B12 absorption occurs in the terminal ileum via the intrinsic factor receptor (cubam). Folate absorption is maximal in the proximal jejunum via the proton-coupled folate transporter (PCFT). Both are impaired in active coeliac disease.
For athletes, folate deficiency impairs DNA synthesis and red blood cell maturation — contributing to macrocytic anaemia independent of iron status. B12 deficiency affects myelination of peripheral motor nerves, with consequences for reaction time, proprioception, and neuromuscular precision. Sub-clinical B12 deficiency (serum B12 200–350 pmol/L range) often precedes frank clinical anaemia by months and may present as fatigue, cognitive slowing, and impaired coordination.
Gluten-free diets themselves, if poorly planned, may be lower in B vitamins than standard diets due to reduced consumption of fortified cereals and grains. Athletes transitioning to a GFD should audit their B12, folate, and thiamine intake proactively.
---
Calcium, Bone Density, and Stress Fracture Risk
Calcium absorption is vitamin D-dependent and also limited by duodenal surface area. In untreated coeliac disease, net calcium absorption is significantly reduced, combined with elevated fecal calcium losses. Hallert and colleagues confirmed that bone mineral density is consistently lower in coeliac patients at diagnosis compared to age- and sex-matched controls, with a mean T-score deficit of approximately −0.5 to −1.0 SD.
For high-impact endurance athletes already at elevated stress fracture risk (runners, military personnel, female athletes with any history of low energy availability), the combination of coeliac malabsorption with training loads creates significant skeletal risk if left unmanaged.
---
Practical Management for Athletic Performance
The treatment for coeliac disease is strict, lifelong gluten elimination — not reduction, but complete exclusion. Cross-contamination at the 20 ppm threshold can sustain villous atrophy and blunt recovery. Athletes should work with a registered dietitian to audit their nutrition comprehensively during the GFD transition, paying particular attention to iron, calcium, B12, folate, vitamin D, and total caloric adequacy.
Most athletes with coeliac disease see meaningful performance recovery within 6–18 months of strict GFD adherence as intestinal architecture regenerates. Competitive athletes managing diagnosed coeliac disease — particularly those monitoring micronutrient adequacy on a gluten-free dietary pattern — can use the disease-specific nutrition guidance at winsport.uk/tools/health/chronic-disease-nutrition-guide to cross-reference their intake targets against clinical deficiency thresholds.
If you have unexplained fatigue, persistent low ferritin, or stress fractures despite adequate training nutrition, when did you last get coeliac serology tested?